Unlocking the potential of synthetic DNA
Drug Discovery World
NOVEMBER 20, 2023
Raquel Sanches-Kuiper , Vice President of Science and Applications at Evonetix, and Clare Whitewoods , Marketing Communications Manager at Evonetix, look at the benefits synthetic DNA brings to pharmaceutical development. Their speed also allows for their potential use in personalised therapy for diseases such as cancer.
Let's personalize your content